Context With the routinization of evidence-based medicine and of the randomized-controlled trial (RCT), more patients are becoming Ôsites of evidence productionÕ yet, little is known about how they are recruited as participants; there is some evidence that Ôsubstantively valid consentÕ is difficult to achieve.Objective To explore the views and experiences of nurses recruiting patients to randomized-controlled trials and to examine the extent to which their recruitment practices were patient-centred and patient empowering.Design Semi-structured in-depth interviews; audio recording of recruitment appointments; thematic interactional analysis (drawing on discourse and conversation analysis).Setting and participants Nurses recruiting patients to five publicly funded RCTs and patients consenting to the recording of their recruitment sessions.Main outcome measures The views of recruiting nurses about their recruitment role; the extent to which nurse-patient interactions were patient-centred; the nature of the nursesÕ interactional strategies and the nature and extent of patient participation in the discussion.Results The nurses had a keen sense of themselves as clinicians and patient advocates and their perceptions of the trial and its interventions were inextricably linked to those of the patients. However, many of their recruitment practices made it difficult for patients to play an active and informed part in the discussion about trial participation, raising questions over the quality of consent decisions.Conclusion Nurses working in patient recruitment to RCTs need to reconcile two different worlds with different demands and ethics.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.